A practical guide to setting up a repetitive transcranial magnetic stimulation (rTMS) service

Australasian Psychiatry

Volumn 18, Issue 4, 2010, Pages 314-317

  Galletly, Cherrie ^a,b   Fitzgerald, Paul ^c   Clarke, Patrick ^d   Gill, Shane ^d   Burton, Cassandra ^d   Turnbull, Carol ^d  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b Ramsay Health Care   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d Adelaide Clinic   (Australia)

Author keywords

Antidepressant; Depression; Repetitive transcranial magnetic stimulation; RTMS; Service development

Indexed keywords

CLINICAL RESEARCH; DEPRESSION; FUNDING; HUMAN; MEDICAL ETHICS; MENTAL HEALTH SERVICE; SHORT SURVEY; TRANSCRANIAL MAGNETIC STIMULATION;

ADULT; AUSTRALIA; CLINICAL PROTOCOLS; DEPRESSIVE DISORDER, MAJOR; FEMALE; HOSPITALS, PRIVATE; HUMANS; MALE; MENTAL HEALTH SERVICES; MIDDLE AGED; NEW ZEALAND; SEVERITY OF ILLNESS INDEX; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

EID: 77954868508     PISSN: 10398562     EISSN: 14401665     Source Type: Journal    
DOI: 10.3109/10398561003686771     Document Type: Short Survey

References (13)

1. Padberg F, George MS. Repetitivetranscranial magnetic stimulation of the prefrontal cortex in depression. Experimental Neurology 2009; 219 : 2-13.
2. Schutter DJLD. Antidepressant efficacy of high-frequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind sham-controlled designs: a meta-analysis. Psychological Medicine 2009; 39 : 65-75.
3. Federal Drugs Administration. N euronetics (510K) Summary. Available from URL: http:// www.accessdata.fda.gov/cdrh-docs/pdf8/K083538.pdf
4. Fitzgerald PB, Brown T, Marston NAU, Daskalakis ZJ, Kulkarni J. A double-blind placebo controlled trial of transcranial magnetic stimulation in thetreatment of depression. Archives of General Psychiatry 2003; 60 : 1002-1008.
5. O'Reardon JP, Solvason HB, Janicak PG et al. Efficacy and safety of transcranial magnetic stimulation in the acutetreatment of major depression: a multisite randomized controlled trial. Biological Psychiatry 2007; 62 : 1208-1216.
6. The Royal Australian and New Zealand College of Psychiatrists. Clinical Memoranda #18: Transcranial Magnetic Stimulation (TMS). Available from URL: http://www.ranzcp. org/images/stories/ranzcp-attachments/Resources/College- Statements/Clinical- Memoranda/cm18.pdf. p. 2.
7. Keel JC, Smith MJ, Wassermann EM. A safety screening questionnaire for transcranial magnetic stimulation. Clinical Neurophys iology 2001; 112 : 720.
8. George MS, Belmaker RH. T ranscranial Magnetic Stimulation in Psychiatry. Arlington: American Psychiatric Association Publishing, 2007; 57.
9. Rodriguez-Martin JL, Barbanoj JM, Schlaepfer TE et al. Transcranial magnetic stimulation for treating depression. Cochrane Database of Systematic Reviews 2001, Issue 4. Art. No.: CD003493. DOI: 10.1002/14651858.CD003493.
10. Fitzgerald PB, Benitez J, de Castella A, Daskalakis ZJ, Brown TL, Kulkarni J. A randomized, controlled trial of sequential bilateral repetitivetranscranial magnetic stimulation for treatment-resistant depression. American Journal of Psychiatry 2006; 163 : 88-94. (Pubitemid 43050108)
11. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 1960; 23 : 56-62.
12. Rush AJ, Fava M, Wisniewski SR et al. Sequenced Treatment Alternatives to Relieve Depression (STAR*D): rationale and design. Controlled Clinical Trials 2004; 25 : 119-142. (Pubitemid 38230109)
13. Simpson KN, Welch MJ, Zozel FA, Demitrack MA, Nahas Z. Cost-effectiveness of transcranial magnetic stimulation in thetreatment of major depression: a health economics analysis. Advances in Therapy 2009; 26: 346-368.